(Q34715238)

4 August 2017

1 reference

title

Laboratory diagnosis of cysticercosis (English)

1 reference

4 August 2017

Laboratory Diagnosis of Cysticercosss (English)

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

29 November 2022

0 references

Richards F Jr

1

1 reference

4 August 2017

F. Richards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1802519

29 November 2022

P. M. Schantz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1802519

29 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1802519

29 November 2022

publication date

1 December 1991

1 reference

full work available at URL

4 August 2017

https://api.elsevier.com/content/article/PII:S0272271218305328?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

https://api.elsevier.com/content/article/PII:S0272271218305328?httpAccept=text/plain

29 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Clinics in laboratory medicine

29 November 2022

published in

1 reference

4 August 2017

volume

11

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

1011-1028

1 reference

Neurocysticercosis. Short course of treatment with albendazole

4 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Immunodiagnosis of taeniasis by coproantigen detection.

29 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

A rapid immunoblot assay (western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni, and Taenia solium (Cysticercosis).

29 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

MR findings in extracranial cysticercosis.

29 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Evaluation of enzyme-linked immunosorbent assay in serological diagnosis of human neurocysticercosis using paired samples of serum and cerebrospinal fluid

29 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Generalized muscular pseudohypertrophy in cysticercosis

29 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

ELISA antibodies to cysticerci of Taenia solium in human populations in New Guinea, Oceania, and Southeast Asia

29 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Results of surgical treatment of neurocysticercosis in 69 cases.

29 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis

29 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid

29 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Detection of Taenia hydatigena copro-antigens by ELISA in dogs.

29 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico

29 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis

29 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel

29 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cerebral cysticercosis: diagnostic value of subcutaneous nodules. Report of two cases.

29 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Comparison of two assays (EIA and EITB) and two samples (saliva and serum) for the diagnosis of neurocysticercosis.

29 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Neurocysticercosis in Mexico

29 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Specific detection of Taenia saginata eggs by DNA hybridisation

29 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens

29 November 2022

30

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Antigen-antibody analyses in neurocysticercosis

29 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cysticercosis of the brain shown by magnetic resonance imaging

29 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Potential hazard of mass praziquantel use

29 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Treatment of neurocysticercosis

29 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

A modification of the formol-ether concentration technique for increased sensitivity in detecting Schistosoma mansoni eggs

29 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cerebral cysticercosis: documentation of natural history with CT.

29 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Eosinophils in the Cerebrospinal Fluid

29 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cysticercosis cerebri. Review of 127 cases

29 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Computed tomography (CT) in parenchymatous cerebral cysticercosis

29 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases.

29 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Computed tomography in neurocysticercosis

29 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Intraparenchymal cerebral cysticercosis in children: a benign prognosis.

29 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Treatment of neurocysticercosis: is praziquantel the new hope?

29 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Recent advances in the diagnosis and treatment of cerebral cysticercosis

29 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Serological detection of cysticercosis in two rural areas of South Africa

29 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cysticercotic encephalitis: a severe form in young females

29 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Treatment of Taenia solium infections

29 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Cysticercosis in Los Angeles County

29 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Molecular cloning of Taenia solium genomic DNA and characterization of taeniid cestodes by DNA analysis

29 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Long-term results of praziquantel therapy in neurocysticercosis

29 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

The role of computed axial tomography in the diagnosis and treatment of brain inflammatory and parasitic lesions: our experience in Mexico

29 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

29 November 2022

CNS cysticercosis.

70

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Praziquantel therapy for cysticercosis

29 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Neurocysticercosis. Two hundred thirty-eight cases from a California hospital

29 November 2022

75

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

[Behavior of the indirect immunofluorescence reaction and of cerebrospinal fluid parameters in neurocysticercosis]

29 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

29 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Therapy of parenchymal brain cysticercosis with praziquantel.

29 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases

29 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Praziquantel in the treatment of neurocysticercosis: long-term follow-up.

29 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

The successful removal of a subretinal cysticercus by pars plana vitrectomy

29 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Neurosurgical considerations of cysticercosis of the central nervous system

29 November 2022

86

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

MR imaging of neurocysticercosis

29 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Seizures and praziquantel. A case report

29 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections

29 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Selective indications for the use of praziquantel in the treatment of brain cysticercosis

29 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Observations on the structure of cysticerci of Taenia solium and Taenia saginata (Cestoda: Taeniidae)

29 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel

29 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Multiple nodules on the tongue of a patient with seizures.

29 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Ocular cysticercosis. A report of 13 cases

29 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.

29 November 2022

103

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

The development of nonradioactive total genomic probes for strain and egg differentiation in taeniid cestodes

29 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

Ethyl acetate as a substitute for diethyl ether in the formalin-ether sedimentation technique

29 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

MR imaging of neurocysticercosis

29 November 2022

109

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

The relationship of antibody levels to the clinical spectrum of human neurocysticercosis

29 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/S0272-2712(18)30532-8

29 November 2022

Identifiers

1 reference